NPPB and heart failure: BNP and NT-proBNP are biomarkers listed in up-to-date European Cardiology Society recommendations for heart failure management as well as evaluated in the population of patients with ACS history.[25–27] The relationship between the concentration of NT-proBNP and the risk for hospitalization and mortality is curvilinear in patients with ACS.